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Protein kinase A-anchoring proteins (AKAPs) localize
the second messenger response to particular subcellular
domains by sequestration of the type II protein kinase A.
Previously, AKAP120 was identified from a rabbit gas-
tric parietal cell cDNA library; however, a monoclonal
antibody raised against AKAP120 labeled a 350-kDa
band in Western blots of parietal cell cytosol. Recloning
has now revealed that AKAP120 is a segment of a larger
protein, AKAP350. We have now obtained a complete
sequence of human gastric AKAP350 as well as partial
cDNA sequences from human lung and rabbit parietal
cells. The genomic region containing AKAP350 is found
on chromosome 7q21 and is multiply spliced, producing
at least three distinct AKAP350 isoforms as well as
yotiao, a protein associated with the N-methyl-D-aspar-
tate receptor. Rabbit parietal cell AKAP350 is missing a
sequence corresponding to a single exon in the middle of
the molecule located just after the yotiao homology re-
gion. Two carboxyl-terminal splice variants were also
identified. Both of the major splice variants showed tis-
sue- and cell-specific expression patterns. Immunofluo-
rescence microscopy demonstrated that AKAP350 was
associated with centrosomes in many cell types. In po-
larized Madin-Darby canine kidney cells, AKAP350 lo-
calized asymmetrically to one pole of the centrosome,
and nocodazole did not alter its localization. During the
cell cycle, AKAP350 was associated with the centro-
somes as well as with the cleavage furrow during an-
aphase and telophase. Several epithelial cell types also
demonstrated noncentrosomal pools of AKAP350, espe-
cially parietal cells, which contained multiple cytosolic
immunoreactive foci throughout the cells. The localiza-
tion of AKAP350 suggests that it may regulate centroso-
mal and noncentrosomal cytoskeletal systems in many
different cell types.
Transduction of signals from extracellular stimuli is most
commonly accomplished via ligand-receptor binding and gen-
eration of a second messenger response. While increases in
intracellular second messengers have traditionally been
viewed as global cellular events, second messenger effects are
often limited to particular regions or organelles within cells.
Investigations over the past decade have led to a greater un-
derstanding of the mechanisms responsible for the compart-
mentalization of second messenger effects. These studies have
identified a diverse group of scaffolding proteins that sequester
both protein kinases and protein phosphatases within specific
cellular domains (1, 2). In the case of cAMP-dependent protein
kinases, protein kinase A-anchoring proteins (AKAPs)1 tether
the protein kinase A holoenzyme through binding to the regu-
latory subunit dimer. A growing group of AKAPs that bind the
regulatory subunit of type II protein kinase A (RII) have been
reported over the past several years. The first RII-binding pro-
tein was identified over 15 years ago when microtubule-asso-
ciated protein 2 (MAP-2) was described (3, 4). Since that time,
several AKAPs have been identified, localizing the type II
protein kinase A to thyroid cytoskeleton (5), mitochondria (6),
the Golgi apparatus (7, 8), centrosomes (8, 9), and microtubules
(7, 10), among other places. More recently, an AKAP with
binding capacity for the regulatory subunits of type I protein
kinase A has also been reported (11).
A number of AKAPs are associated with the cell cytoskeleton
and appear to regulate plasma membrane events possibly
through anchoring at the sites of interaction between cytoskel-
etal elements and membrane receptors and channels. Ezrin, a
member of the ERM family of F-actin-associated proteins that
is phosphorylated in response to mediators that elevate cAMP
responses in gastric parietal cells (12), contains an am-
phipathic a-helix that binds RII (13). AKAP100, which is en-
riched in cardiac and skeletal muscle (14), localizes the type II
protein kinase A to the sarcoplasmic reticulum and is hypoth-
esized to play a role in the regulation of membrane channel
activity. Similarly, protein kinase A anchoring to the postsyn-
aptic densities (15) by AKAP79 is required for modulation of
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AMPA-kainate currents in hippocampal neurons (16). AKAP15
targets type II protein kinase A to L-type calcium channels in
transverse tubules of skeletal muscle and influences rapid volt-
age-dependent potentiation (17). MAP-2 binds type II protein
kinase A and sequesters it in association with dendritic micro-
tubules (4). Phosphorylation of MAP-2 by protein kinase A
inhibits microtubule nucleation in vitro (3). The distribution of
all of these AKAPs suggests that specific scaffolding functions
can account for subcellular signaling specificity.
We have previously reported the cloning and initial charac-
terization of a protein kinase A-anchoring protein, AKAP120,
from a rabbit gastric parietal cell cDNA library (18). It is now
apparent that the initial AKAP120 sequence is a fragment of a
larger 350-kDa AKAP (AKAP350). We have completed the se-
quence of human AKAP350, which represents a multiply
spliced family of proteins coded for by a single gene sequence on
human chromosome 7q21. Immunolocalization demonstrates
that AKAP350 is associated with centrosomes in many cells
and also shows noncentrosomal organization in certain epithe-
lial cells, including gastric parietal cells.
EXPERIMENTAL PROCEDURES
Materials—Recombinant RII was purified from bacteria expressing
the protein based on a pET11D-RII expression vector (a gift of Dr. John
Scott, Vollum Institute). A human tracheal epithelia-enriched Lambda-
Zap cDNA library was a gift from Drs. S. Gabriel and D. Fenstermacher
(University of North Carolina, Chapel Hill). Cultured CalU3 and
HBE16Eo cells were a gift of Dr. J. Stutts (University of North Caro-
lina, Chapel Hill). Polyclonal anti-g-tubulin antibody was purchased
from Babco (Berkeley, CA). Monoclonal anti-g-tubulin was purchased
from Sigma. Cy2-, Cy3-, and Cy5-conjugated secondary antibodies were
purchased from Jackson ImmunoResearch Labs (West Grove, PA). Ef-
fectene transfection reagent was obtained from Qiagen (Valencia, CA).
Prolong Antifade, 49,6-diamidino-2-phenylindole, and Alexa 488-conju-
gated secondary antibodies were from Molecular Probes, Inc. (Eugene,
OR). E-GFP-C2 vector, Advantage Taq, and Marathon cloning kits were
purchased from CLONTECH. All DNA sequencing was performed us-
ing dye terminator chemistry automated sequencing in the Molecular
Biology Core Facility at the Medical College of Georgia or the DNA
Sequencing Facility, University of North Carolina. Oligonucleotides
were also synthesized by the Molecular Biology Core Facility.
[a-32P]dCTP was purchased from NEN Life Science Products. Random
priming kits were purchased from Amersham Pharmacia Biotech.
HCT116 cells were obtained from ATCC.
Monoclonal Antibody Production—Recombinant polyhistidine-
tagged AKAP120-(183–1022) was prepared by the methods of Drans-
field et al. (18). Recombinant protein was used to immunize mice, and
serum titers were monitored by enzyme-linked immunosorbent assay
using the recombinant protein (19). Splenocytes were harvested and
fused with myeloma cells. Culture supernatants from the resulting
hybridomas were screened by enzyme-linked immunosorbent assay,
and productive cell wells were cloned to monoclonal lines by serial
dilutional screening. Four monoclonal antibodies were prepared that
also detected protein in Western blots. The 14G2 monoclonal antibody,
an IgG1, was used for the present studies because of its detection
sensitivity. Monoclonal antibodies were concentrated by preparation of
purified IgG from culture supernatants (University of Georgia Mono-
clonal Facility, Athens, GA).
EGFP-AKAP120—Full-length AKAP120 nucleotide sequence previ-
ously cloned into pBluescript (18) was excised with an EcoRI restriction
digest and ligated in-frame into the pEGFP-C2 vector (CLONTECH).
100 ng of plasmid DNA was transiently transfected into MDCK cells
(35-mm dishes) with the Effectene reagent (Qiagen) according to the
manufacturer’s instructions (20). Cells were grown to confluency and
lysed with 1% SDS stop solution.
Western Blot Analysis—Sample extracts from cells and tissues were
resolved by SDS-PAGE (3–10% gradient gels) and transferred for 2 h at
750 mA to nitrocellulose (0.22 mm) for subsequent Western blotting.
Nitrocellulose blots were blocked with 5% nonfat dry milk in 25 mM
Tris-HCl, pH 7.5, 150 mM NaCl for 16–24 h at 4 °C. Blots were then
probed in 0.5% nonfat dry milk in 25 mM Tris-HCl, pH 7.5, 150 mM NaCl
for 1 h at room temperature with a monoclonal antibody against
AKAP350 (14G2; 1:500). After the primary incubation, the blots were
washed three times for 15 min each with 25 mM Tris-HCl, pH 7.5, 150
mM NaCl and then incubated with horseradish peroxidase-conjugated
anti-mouse IgG (1:2500) for 1 h at room temperature. The blots were
finally washed three times for 15 min each with 25 mM Tris/HCl,
pH 7.5, 150 mM NaCl, and immunoreactivity was detected with
chemiluminescence (Renaissance; NEN Life Science Products) and
autoradiography.
Cloning and Sequencing of AKAP350—Both 39- and 59-rapid ampli-
fication of cDNA ends (RACE) were used to clone the human gastric
AKAP350 beginning with sequence information from the human
genomic BAC AA004013, which showed homologies with the original
AKAP120 sequence. A single 39-RACE and multiple rounds of 59-RACE
were performed with the Marathon system (CLONTECH) to complete
the recloning of human AKAP350 from an end-adapted human gastric
cDNA (Marathon cDNA, CLONTECH). Similarly, a rabbit parietal cell
cDNA with Marathon adapters was constructed from poly(A) mRNA
from a greater than 95% pure rabbit parietal cell preparation. All RACE
products were cloned into pBluescript-T (21). Further human sequence
information was obtained from the total sequencing of an expressed
sequence-tagged cDNA from the human promyeloblast cell line KG1a,
PMY2245 (22). Finally, biotinylated recombinant RII was used to screen
a human tracheal cDNA library in LambdaZap using a standard pro-
tein overlay technique. Phage plaques were identified by incubation in
streptavidin-alkaline phosphatase followed by colorimetric detection
with a nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate
substrate. Clones were rescued into pBluescript and sequenced. One
clone showed homology with rabbit AKAP120 and was sequenced
completely.
Northern Blot Analysis—Total rabbit RNAs were prepared from
.95% pure parietal cells, gastric fundic mucosa, and lung (23). mRNA
was resolved on 1% agarose/formaldehyde gels and transferred to Mag-
nagraph (MSI, Westboro, MA). A human multitissue Northern blot was
purchased from CLONTECH. Rabbit blots were probed with a 1650-nt
probe corresponding to the 39-end of rabbit AKAP350 labeled by random
priming in the presence of [a-32P]dCTP. Human blots were probed with
both a 1650-nt probe corresponding to the 39-end of human gastric
AKAP350 or a 1600-nt probe corresponding to the 59-end of human lung
AKAP350. Blots were probed overnight at 42 °C and then washed to
high stringency (0.13 SSC, 65 °C). Dried blots were exposed to either
x-ray film at 270 °C or PhosphorImager screens for 72 h.
Splice Variant Analysis—Total RNAs were prepared from tissues
and cells using RNASTAT-60 (23). The Advantage RT for PCR kit
(CLONTECH) was used to construct cDNA from 2 mg of total RNA
using random hexamer primers. Rabbit cDNAs were constructed for
parietal cell, spleen, liver, kidney, lung, heart, forebrain, hind brain,
and cerebellum and for mucosa from fundus, antrum, duodenum, jeju-
neum, ileum, and colon. Human cDNAs were also prepared from total
RNA obtained from stomach, lung, and kidney, as well as the CalU3
and HBE16Eo cell lines. Gene-specific primers were constructed imme-
diately upstream and downstream from the splice 1 exon (sense, GAA-
CAGTTGGAAGATATGAGACAGGAAC; antisense, GATGCCTCTGCT-
TCTGACCTCCA), and products were amplified using Advantage
Polymerase (CLONTECH) with 40 cycles: 95 °C for 15 s, 60 °C for 10 s,
and 68 °C for 60 s. Amplified products were separated on 2% Nuseive
3:1 agarose gels. To amplify the alternative 39-end coding sequences
(splice 2) in human samples, a common sense primer (GGTCGGCCGT-
CAGAGTATCC) paired with antisense primers specific for either the
gastric sequence (AGGATTATCTTCTCATGCCAGCA) or the sequence
derived from human lung (ATCCTAATGAGTGTGAAAGAATT) were
employed using the same amplification protocol described above. The
identities of amplified products were confirmed by gel isolation and
DNA sequencing.
Immuncytochemistry in Rabbit Tissues—For investigation of tissue
distribution, under anesthesia New Zealand White rabbits were canu-
lated through the distal aorta and perfused sequentially with phos-
phate-buffered saline (PBS) followed by 4% paraformaldehyde in phos-
phate buffer, pH 7.4. Tissues were excised and post-fixed for 2 h in 4%
paraformaldehyde and then infiltrated with sucrose and embedded in
OCT medium. Five-mm frozen sections were cut and mounted on gela-
tin-coated slides. For staining of gastric glands, isolated gastric glands
were prepared from New Zealand White rabbits as described previously
(24). Glands were fixed in 4% paraformaldehyde for 30 min at 4 °C,
washed in cold PBS, and then permeabilized with 0.3% Triton X-100 in
PBS. Glands were then adhered to polylysine-coated slides.
For staining glands and frozen tissue sections, slides were blocked
with 17% donkey serum for 30 min and then incubated with 14G2
monoclonal antibody (1:50) or a class-matched nonspecific monoclonal
IgG (Sigma) for 2 h at room temperature or overnight at 4 °C. Following
washing, antibody localization was detected with incubation with Cy3-
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donkey anti-mouse IgG antibodies for 30 min at room temperature.
Slides were mounted with Prolong Antifade solution (Molecular
Probes). Tissue sections were examined under a Zeiss Axiphot micro-
scope equipped with a Sensys digital camera (Photometrics). Gastric
glands were examined with confocal fluorescence microscopy (Molecu-
lar Dynamics, IMMAG Imaging Core Facility) using maximum inten-
sity projections assembled from 40 0.29-mm optical sections.
Immunocytochemistry in Cultured Cells—HCT116 colon adenocarci-
noma cells were plated sparsely on number 1 glass coverslips for 24 h.
Cells were washed in PBS and briefly permeabilized in 1% Triton
X-100, 45 mM Pipes, 45 mM Hepes, pH 6.9, 10 mM EGTA, 5 mM MgCl2,
0.5 mM AEBSF for 60 s at 4 °C followed by fixation in 220 °C methanol
for 6 min. Cells were blocked with 17% donkey serum, 0.1% Tween 20
in PBS and then incubated simultaneously with 14G2 (1:30) and rabbit
anti-g-tubulin (1:400) for 2 h at room temperature. The cells were then
simultaneously incubated with ALEXA-488-conjugated anti-mouse IgG
and Cy5-conjugated anti-rabbit IgG for 60 min. Following washing in
PBS, the cells were incubated in 49,6-diamidino-2-phenylindole (1 mM)
for 5 min and washed in PBS. Coverslips were inverted and mounted
with Prolong Antifade. Cells were examined for triple labeling on an
Axiophot microscope as described above.
For immunolocalization in MDCK cells, MDCK (type II) cells were
grown on 23-mm Transwell clear filters for 3 days to establish highly
polarized monolayers. HBE cells were cultured on Transwell filters for
3 days. Cells were then fixed as above for HCT116 cells. Cells were
permeabilized and blocked in 10% donkey serum and then incubated
with the following primary antibody: 14G2 monoclonal antibodies (1:
30); polyclonal rabbit anti-RII (1:1000); rat monoclonal anti-ZO-1 (1:100,
a tight junction marker); rabbit anti-g-tubulin (1:400); or murine anti-
g-tubulin (1:250). Antibodies were visualized with secondary antibodies
conjugated with Cy2, Cy3, and Cy5. Immunostained cells were exam-
ined by confocal microscopy using maximum intensity projections of 40
0.29-mm optical sections.
Parietal Cell Preparations—Isolated gastric glands and isolated pa-
rietal cells were prepared from New Zealand White rabbits as described
previously (25). Subfractions of gastric parietal cells were prepared by
sequential centrifugation of homogenates at 1000, 4000, 15,000, and
100,000 3 g to prepare four microsomal pellets and a final high speed
supernatant fraction (26). Parietal cells were maintained in primary
culture on Matrigel-coated coverslips, as described previously (27). For
immunocytochemistry, cultured cells were fixed as for HCT116 cells.
Cells were dual-stained as described above with 14G2 and polyclonal
anti-g-tubulin.
RESULTS
Identification of Endogenous AKAP120 Immunoreactivity—
Recombinant polyhistidine-tagged AKAP120-(183–1022) was
used to make a monoclonal antibodies against the AKAP. West-
ern blots of rabbit parietal cell cytosolic proteins probed with
the monoclonal antibody for AKAP120 (14G2) revealed a major
band at 350 kDa and a variably detected 250-kDa band (Fig. 1).
A 200-kDa band was also intermittently noted. In parietal
cells, the variable observation of the 200- and 250-kDa immu-
noreactive bands in multiple preparations has suggested that
they are proteolytic breakdown products. In preparations of
protein from rabbit parietal cell subfractions, more than 85% of
the total AKAP350 was found in the high speed supernatant
(data not shown). A similar banding pattern was seen in a
survey of other rabbit tissues by Western blots of protein from
duodenum, jejunum, ileum, colon, and liver (Fig. 1). While the
most prominent immunoreactive species in all rabbit tissues
was a 350-kDa band, 250- and 200-kDa species were also ob-
served. Western blots of cultured epithelial cell lysates also
were examined, including nonpolarized HeLa cells and polar-
ized MDCK cells (Fig. 1). Both cultured cell lines demonstrated
the 350- and 250-kDa immunoreactive bands. In the MDCK
cells, the 250-kDa species was consistently more prominent,
although the ratio between the 250- and 350-kDa bands varied
considerably.
Although AKAPs tend to migrate in acrylamide gel electro-
phoresis to higher than predicted molecular weights (8), in
light of the Western blots, it was necessary to investigate the
possibility that the full-length sequence of the AKAP had not
been cloned. A single experiment provided the necessary evi-
dence that the sequence was incomplete. The known AKAP120
sequence was cloned into the pEGFP-C2 vector and transiently
transfected into MDCK cells. Duplicate Western blots of cell
lysates were then probed with anti-AKAP120 (14G2) and anti-
EGFP antibodies. The 14G2 antibody recognized the endoge-
nous 250- and 350-kDa bands as well as a 150-kDa band;
however, only the 150-kDa band was seen when probing with
anti-EGFP (data not shown). This result indicated that
AKAP120 cDNA sequence could not account for endogenous
immunoreactive proteins, and therefore the full-length se-
quence had not been cloned.
Cloning of AKAP350—We sought to complete the cloning
from rabbit parietal cells and human gastric cDNAs. Both 39-
and 59-RACE were used to identify the remainder of the nucle-
otide sequence. Because a human genomic DNA sequence from
chromosome 7q21 corresponding to AKAP120 became available
at the time, we chose to focus on the human clone. This has led
to the cloning of the full-length human sequence composed of
11,490 base pairs with an open reading frame of 10,593 nucle-
otides (Fig. 2). The 59-end of the sequence contains a strong
consensus initiation sequence, which is preceded by two up-
stream in-frame stop codons. From the first in-frame ATG, this
sequence codes for 3531 amino acids with a predicted molecular
mass of 409 kDa and a pI of 4.8. Because of its migration in
SDS-PAGE, we have named this new full-length sequence
AKAP350. The sequence contains 58 phosphorylation sites for
protein kinase C, 56 for casein kinase II, and three for tyrosine
kinase. protein kinase A phosphorylation sites are predicted at
residues 1860, 2285, 2727, and 3076. An RII binding region
previously identified in the AKAP120 sequence is found from
amino acid 2174 to 2187 in the human AKAP350 (Fig. 2). These
sites are identical except for a single isoleucine to valine sub-
stitution, which should not affect the integrity of the am-
phipathic helix. Four leucine zipper motifs are present between
amino acids 313 and 334, 391 and 412, 2651 and 2672, and
3211 and 3239 (Fig. 2).
A closer examination of the peptide sequence for AKAP350
reveals a structure involving multiple coiled-coil domains
throughout the protein, especially from amino acid 739 to 2270.
The AKAP350 protein is 15.3% glutamate, 9.3% glutamine,
and 12.4% leucine by total amino acid composition. In 62
individual locations, two consecutive glutamate residues are
found, and in 21 locations, two consecutive glutamine resi-
FIG. 1. Immunoreactivity with 14G2 monoclonal antibody.
Western blots demonstrated a 350-kDa immunoreactive band (upper
arrow), as well as the intermittently detected 250- (lower arrow) and
200-kDa bands in protein extracts (50 mg/lane). Left, immunoreactivity
was compared between isolated rabbit parietal cells (PC) and the fol-
lowing rabbit gastrointestinal tissues: duodenum (D), jejunum (J), il-
eum (I), colon (C), and liver (L). Right, comparison of rabbit parietal
cells with lysates from HeLa cells (H) and MDCK (M) cells.
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FIG. 2. Alignment of full nucleotide and amino acid sequence for human gastric AKAP350. The positions of the RII binding site
(underlined) and the four leucine zippers (highlighted) are noted.
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dues are found.
By conducting searches of on-line data bases including
Fasta, PROSITE, and BLAST, other proteins possessing sig-
nificant homology with the human AKAP350 were identified.
The original rabbit parietal cell AKAP120 protein sequence is
78% identical to the human gastric AKAP350 (HGAKAP350)
sequence. Yotiao, a recently described ligand of the NR-1 sub-
unit of the NMDA receptor (29) shares the same genomic DNA
region as AKAP350. This protein is 99% identical to amino
acids 1–1249 (YHR, Fig. 3) of HGAKAP350. The human
FIG. 2—continued
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AKAP350 cDNA maps onto chromosome 7q21 in the genomic
DNA of BACs 4013, 0066, 3086, and 0120 while splicing in and
out of yotiao exons. Approximately 50% of the coding sequence
for yotiao is found in exons for AKAP350. Another protein with
significant homology is pericentrin, a 220-kDa coiled-coil pro-
tein found in centrosomes and pericentriolar material. Pericen-
trin shares a 21% identity and 47% similarity with AKAP350.
Other centrosomal associated proteins sharing similarity with
AKAP350 include CENP-F (20.7%), and CEP250 (20.2%).
Other cytoskeletal proteins with 20–24% identity include two
intermediate filament binding proteins, plectin and tricohya-
lin, as well as a number of other proteins with extensive coiled-
coil domains including myosin heavy chain, giantin, and the
Golgi antigen GCP372.
Additional sequence for AKAP350 was acquired by examina-
tion of other cDNAs obtained from human lung, rabbit parietal
cell, and the longest expressed sequence tag with homology to
the known AKAP sequence, PMY2245 (Fig. 3). Sequencing of
the PMY2245 clone from a human promyeloblast cell line
revealed 100% identity to the human gastric AKAP350
(HGAKAP350) over approximately 4 kb of sequence at the
39-end (Fig. 3). Human lung cDNA yielded a clone
(HLAKAP350) with 99% protein identity and 95% DNA iden-
tity over a 4-kb segment also at the 39-end of the AKAP. From
rabbit parietal cell cDNA, a partial sequence was obtained from
59- and 39-RACE products, accounting for all but the 1000 nt at
the 59-end, 91% of the total human gastric AKAP350, with 87%
protein identity and 87% DNA identity to HGAKAP350.
AKAP350 Genomic Structure—A comparison of the resolved
cDNA sequences from human stomach, human lung, rabbit
parietal cells, and the expressed sequence tag cDNA
(PMY2245) with the genomic sequences have allowed us to map
the exons of this gene. The AKAP350 exons are scattered over
200 kb of genomic DNA (Fig. 4a). This genomic region appar-
ently codes for a multiply spliced gene that includes DNA for
the yotiao protein and several forms of AKAP350. Upstream
from the first yotiao exon, there is a GC-rich region that prob-
ably represents a TATA-less promoter. The first exon of
AKAP350 lies between exons 9 and 10 of yotiao. Upstream from
the AKAP350 first exon is a promoter region that contains two
putative TATA box elements.
At least three major sites of alternate splicing exist in the
AKAP350 sequence. The first location is a highly spliced region
where three separate splice choices are made including a read-
through to complete the final yotiao exon or a choice in
AKAP350 of two different splice acceptors for a common splice
donor (Fig. 4b). The latter splice variant (Fig. 4b) was observed
in the rabbit parietal cell AKAP350 cDNA sequence, represent-
ing the loss of an entire exon immediately following the yotiao
homology region. To examine the incidence of this splice vari-
ant, this region was amplified from multiple rabbit tissue
cDNAs with specific primers (Fig. 5a). Most mucosal tissues
from rabbit gastrointestinal tract predominantly express the
transcript with the S1 region deleted. Overloading of samples
reveals that parietal cells and other gastrointestinal mucosae
do express a small amount of the larger transcript. In contrast
with the mucosal samples, in smooth muscle from the gastric
wall the larger splice variant predominates. Other rabbit tis-
sues such as heart and brain reveal the presence of the larger
variant exclusively. The third (highest) band observed in fore-
brain, hind brain, and cerebellum was sequenced and found to
be an artifactual amplification of phosphofructokinase.
Alternative splicing also was found at the C terminus of the
protein (Fig. 4c). While the human gastric, rabbit parietal cell,
and promyeloblast cDNAs all showed the same 39 sequences,
the cDNA obtained from the tracheal cDNA library
(HLAKAP350) demonstrated a different 39 sequence resulting
from a read-through extending past the splice donor site (sim-
ilar to that seen for the final yotiao exon). This “missed splice”
allows the cDNA sequence to continue for another 435 base
pairs before terminating. The incidence of these variants was
again surveyed using locus-specific primers and amplification
from cDNA of several human tissues and the Calu-3 and HBE
cultured cell lines (Fig. 5b). Both splice variants were observed
in pancreas, gastric and lung cDNAs (Fig. 5b). However, the
497-base pair product, which is characteristic of the cDNA
derived from the human tracheal cDNA, was not observed in
either Calu-3 or HBE cells. Only the 397-base pair product was
observed in these cell lines.
Finally, comparison of the PMY2245 cDNA from promyelo-
blasts with the sequences from human lung and human stom-
ach showed a loss of 8 amino acids (24 nt). Examination of the
genomic sequence showed that a variation in the choice of
splice donor sites accounted for this small sequence deletion.
There are also several instances in the rabbit AKAP350 se-
quence where 1–3 amino acids have been lost or gained. Be-
cause the rabbit genomic sequence is not available, we cannot
presently evaluate whether these differences are due to splice
variation or interspecies variations.
Northern Blot Analysis of AKAP350 Expression—Northern
blotting with the 39 end of HGAKAP350 as a probe, revealed an
11-kb message found in rabbit parietal cells and rabbit fundus,
FIG. 3. Comparison of cDNAs coding for AKAP350. The HGAKAP350 is compared with the structures of the PMY2245 promyeloblast
expressed sequence clone, the HLAKAP350 cDNA, rabbit parietal cell AKAP350 (RAKAP350), and the original rabbit AKAP120 sequence
(RAKAP120). The percentages of protein and DNA sequence identities versus HGAKAP350 are shown at the right. The HGAKAP350 sequence
contained an amino-terminal yotiao homology region (YHR) followed immediately by a site of major splice variants (S1). The RAKAP350 sequence
is missing a single exon at the S1 splice site (see Fig. 5b). Note also the region recognized by the 14G2 monoclonal antibody to AKAP350 (amino
acids 1478–1547 in RAKAP350 and 1854–1958 in HGAKAP350) and the position of the RII binding site.
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as well as in rabbit lung (Fig. 6). Human multitissue Northern
blots probed with either a 1.6-kb fragment from the 59-end of
HLAKAP350 (Fig. 6) or a 1.0-kb fragment of the 39-end of
rabbit parietal cell AKAP350 (data not shown) demonstrated
two bands, 9.5 and 11 kb, most prominent in kidney and skel-
etal muscle and to a lesser extent in lung. Only the 9.5-kb
message was noted in liver, and only the 11-kb message was
observed in heart and brain.
AKAP350 Localization in Rabbit Tissues—To investigate the
subcellular localization of AKAP350, the 14G2 monoclonal an-
tibody was used to stain rabbit tissue sections and isolated
gastric glands. In the gastric fundus, parietal cells demon-
strated multiple foci of immunostaining throughout the cytosol
(Fig. 7a). Confocal fluorescence microscopic examination of iso-
lated gastric glands also demonstrated multiple foci of staining
in parietal cells (Fig. 7b). This immunostaining in parietal cells
did not coincide with staining for either the H/K-ATPase-con-
taining tubulovesicles or F-actin-staining secretory canalicular
membranes (data not shown). In the esophagus, basal cells
appeared to show a single point of bright fluorescence (Fig. 7c).
In the jejunum, the most prominent staining was observed in
submucosal lymphoblasts, which showed a single focus of pe-
rinuclear staining (Fig. 7d). In the ileum and colon, epithelial
cells of the deep crypts were strongly stained with multiple
bright foci just beneath the apical membranes (Fig. 7, e and f).
In pancreatic islets, strong AKAP350 immunostaining was
present in all of the endocrine cells of the islet (Fig. 7g). In
many cells, multiple foci of staining were apparent in the
perinuclear region. In contrast, adrenal medullary cells dem-
onstrated only a single focus of AKAP350 immunostaining in
all cells (Fig. 7h). In the kidney collecting duct, AKAP350
staining was observed as a single focus of staining deep to the
apical membrane (Fig. 7i). Single foci of immunostaining also
were observed in primary and secondary germ cells in the
FIG. 4. Multiple splicing in AKAP350. a, exons composing the DNA sequence for both yotiao and AKAP350 are labeled according to the BAC
in which they are found. S1 and S2 denote the sites of alternative splicing to generate isoforms. Note that the figure shows BAC AA000066 in the
reverse orientation to its numbering in its GenBankTM entry. b, map of the S1 splice region and corresponding amino acid sequence. The shaded
region codes for the terminal 39 end of yotiao. A splice before this sequence to the next exon occurs in human gastric AKAP350, whereas in rabbit
AKAP350 this exon is spliced out. c, map of S2 splice region and corresponding amino acid sequence. The 39 end of both human and rabbit AKAP350
splice into the last exon at a point read through by the AKAP350 sequence in human lung. The HLAKAP350 therefore contains 18 additional amino
aicds, resulting in a larger 39-end in this isoform.
AKAP350 Associated with Centrosomes 3061
testes (Fig. 7j). Finally, in the epithelial cells lining the ductus
efferens and the bronchial epithelium, mutiple foci of AKAP350
immunostaining were observed deep to the apical membranes
(Fig. 7, k and l).
AKAP350 Is Associated with Centrosomes—The perinuclear
localization of AKAP350 in many cells suggested its association
with centrosomes. We therefore studied the localization of
AKAP350 in HCT116, a moderately differentiated colonic ade-
nocarcinoma cell line. In interphase cells, AKAP350 immuno-
staining colocalized with g-tubulin staining (Fig. 8). During
metaphase, AKAP350 immunostaining was concentrated in
both centrosomes colabeling with g-tubulin. However, in both
anaphase and telophase cells, while AKAP350 immunostaining
colocalized with g-tubulin-staining centrosomes, several dis-
crete foci of staining also were present in the cleavage furrow of
dividing cells. An identical distribution during the cell cycle
was also observed in HeLa cells (data not shown). These results
indicate that AKAP350 is associated with centrosomes in rap-
idly dividing cells.
Since HCT116 cells are not polarized, we also sought to
investigate AKAP350 distribution in polarized cells. MDCK
cells, a well established polarized kidney cell line, were grown
on permeable filters. While multiple foci of immunostaining for
RII were present throughout the cytosol, AKAP350 staining
was only present in one focus per cell colabeling with major
points of RII staining (Fig. 9b). Colabeling of MDCK cells for
AKAP350 and g-tubulin showed clear colocalization at the cen-
trosomes; however, there was obvious asymmetry between the
poles. Higher resolution projections demonstrate that
AKAP350 staining predominates in one centriole as a projec-
tion radiating toward the nucleus. Examination of centrosomal
staining with RII antibodies (Fig. 9, m–o) showed a similar RII
immunostaining projection from one pole of the g-tubulin-
staining centrosome. Treatment of MDCK cells with nocoda-
zole (33 mM) to disrupt microtubules did not alter the associa-
tion of either AKAP350 or RII with the centrosomes (data not
shown).
Finally, since several rabbit cells including gastric parietal
cells and bronchial epithelium showed multiple foci of
AKAP350 staining, we also examined in greater detail
AKAP350 staining in primary cultures of rabbit parietal cells
and human bronchial epithelial cells. In parietal cells, multiple
foci of AKAP350 staining were observed throughout the cell
(Fig. 10). One perinuclear focus coincided with staining by
antibodies against g-tubulin, but the vast majority of AKAP350
foci did not correspond with the centrosomes. AKAP350 foci
also did not coincide with F-actin staining of the intracellular
canaliculus (data not shown). In human airway epithelial cells,
the major staining was associated with centrosomes; however,
prominent staining of foci associated with the lateral aspects of
the subapical regions also were present. A similar pattern of
noncentrosomal staining was observed in T84 and HCA-7 colon
adenocarcinoma cells (data not shown).
DISCUSSION
Protein kinase A-anchoring proteins represent a diverse su-
perfamily of scaffolding proteins. This report clarifies the char-
acteristics of a novel multiply spliced AKAP family. Monoclonal
antibodies raised against AKAP120 identified proteins of 350
and 250 kDa in most tissues and cells. AKAP120 was originally
cloned from a rabbit parietal cell cDNA expression library
using 32P-labeled RII as a probe. The single clone isolated
yielded an open reading frame of 3500-nt cDNA coding for a
recombinant expressed protein migrating with an apparent
molecular mass of 120 kDa (18). As described above, eukaryotic
expression of this AKAP sequence as a fusion with the EGFP
indicated that the AKAP120 clone could not account for the
endogenous 350-kDa immunoreactive species. The results of
our cloning experiments reported here show that the original
clone was not full-length and included an erroneous stop codon.
The full-length sequence of AKAP350 contains at least two
major areas for alternative splicing. In addition, genomic se-
quence also contains a major spliced product that codes for the
previously described yotiao protein (29). The present sequence
length matches the major mRNA length observed in rabbit and
human tissues of over 11 kb. Our results demonstrate that
splice variants may be differentially distributed among tissue
and cell types. Indeed, since smaller 9.5-kb species of mRNA
have been identified in Northern blots, it is possible that fur-
ther splice variants may be present.
Previously, a multiply spliced murine AKAP gene has been
described, yielding six isoforms, collectively known as
AKAP-KL (30). Parallel cloning of the AKAP350 in both rabbit
and human has revealed multiple splice variants. Additionally,
the existence of the yotiao protein coding region as a 59-end
splice variant indicates that the AKAP350 genomic region pro-
duces a complex family of protein products from internal alter-
native exon splicing as well as alternative splicing at both the
59- and 39-ends. The function of specific spliced exons remains
to be determined. It is tempting to suggest that specific spliced
exons may account for proper targeting of the AKAP or inter-
action with specific proteins. This possibility appears especially
FIG. 5. Tissue survey for splice variants by the polymerase
chain reaction method. a, the S1 region in Fig. 4 was amplified in an
array of rabbit tissues including parietal cells (PC), fundus (F), gastric
wall smooth muscle (G), antrum (A), jejunum (J), ileum (I), colon (C),
liver (V), spleen (S), kidney (K), lung (L), heart (H), forebrain (FB), hind
brain (HB), cerebellum (CE). b, The S2 region in Fig. 4 was amplified
from cDNA from human pancreas (P), stomach (G), lung (L), Calu-3
cells (C), and human bronchial epithelium (B). For each cDNA, two
reactions were performed: one with an antisense primer specific for the
longer 39 end splice variant (1) and a second time with an antisense
primer specific for the shorter splice (2).
FIG. 6. Northern blots of AKAP350 mRNA expression. Rabbit
(right) tissues were probed with the 39-end of HGAKAP350, revealing
an 11-kb message for rabbit parietal cell (PC), fundus (F), and lung (L).
Human tissue, including kidney (K), skeletal muscle (S), liver (V), lung
(L), placenta (P), brain (B), and heart (H), was probed with a 1-kb
fragment of HLAKAP350.
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possible for the highly spliced region within BAC AA0066,
which contains the alternate splice point for the terminal exon
of yotiao as well as the major internal alternatively spliced
exon in AKAP350, immediately following the yotiao homology
region. The AKAP350 sequence lacking this exon was the ma-
jor sequence in rabbit parietal cells as well as in most gastro-
intestinal mucosae. In contrast, the sequence including this
140-nt sequence was predominant in gastric wall smooth mus-
cle and brain tissue. Interestingly, this exon includes a pair of
adjacent cysteines, perhaps indicative of a possible covalent
cross-linking point either for homodimerization or interaction
with other proteins.
A second major splice variation occurs at the C terminus of
AKAP350 as described above. The AKAP350 sequence isolated
FIG. 7. Distribution of AKAP350 in
rabbit tissues. The distribution of
AKAP350 was examined using the 14G2
monoclonal antibody in tissue sections
and isolated gastric glands (b). AKAP350
staining was localized in frozen sections
of gastric fundic mucosa (a), esophagus
(c), jejunum (d), ileum (e), colon (f), pan-
creatic islet (g), adrenal medulla (h), renal
collecting duct (i), testes (j), ductus effer-
ens (k), and tracheal epithelium (l). Non-
specific staining of large submucosal
macrophages in ductus efferens sections
was also observed in controls incubated
with no primary antibody. Multiple points
of AKAP350 immunofluorescence were
observed in parietal cells of gastric glands
(b) visualized through confocal fluores-
cence microscopy with maximum inten-
sity reconstruction of 40 0.29-mm optical
sections. Bar, 12 mm (a, g, i, and l), 3 mm
(b), 24 mm (c, d, e, f, h, j, k).
FIG. 8. Distribution of AKAP350
during mitosis. HCT116 cells were
plated at low density for 24 h and then
fixed. Cells were triple labeled with poly-
clonal anti-g-tubulin, monoclonal anti-
AKAP350 (14G2) and 49,6-diamidino-2-
phenylindole. A triple label overlay of the
staining patterns is shown at the right.
Based on the 49,6-diamidino-2-phenylin-
dole staining, cells were identified accord-
ing to their mitotic phase as interphase,
metaphase, anaphase, or telophase. At in-
terphase, a single nidus of AKAP350
staining coincided with the g-tubulin
staining adjacent to the nucleus. In met-
aphase, AKAP350 stained both of the cen-
trosomal poles and, in addition, a diffuse
cytosolic staining was also observed. Dur-
ing anaphase and telophase, AKAP350
immunostaining was associated with the
centrosomes, but discrete foci of staining
were also present in the cleavage furrow.
Bar, 3 mm.
AKAP350 Associated with Centrosomes 3063
from the tracheal cDNA library results in an alternative 16
carboxyl-terminal amino acids not found in the human gastric
or the promyeloblast sequence due to a splice variant in the
next to last exon. Since the end of this exon coincides with
multiple consecutive adenosines, it is unlikely that this is the
true 39-end in this mRNA. It is more probable that oligo(dT)
priming occurred internally at the polyadenine in the mRNA
39-untranslated region. Analysis of this splice variant has dem-
onstrated its presence in several tissues. However, while both
39 splice variant sequences were detected in whole lung cDNA,
when we examined cDNA from CalU3 cells (a lung serous cell
line) and a human bronchial epithelial cell line, we were unable
to detect the 39 splice variant originally isolated from the bron-
chial epithelial cell library. Since the library was constructed
from only an enriched population of tracheal epithelial cells, it
seems likely that the message must emanate from a nonepi-
thelial lung cell. These data further suggest that there is a
cell-specific distribution of these AKAP350 isoforms. In addi-
tion to the two major splice variants, the PMY2245 expressed
sequenced tag cDNA also demonstrated a minor splice variant
yielding a deletion of eight amino acids (24 nt) because of an
alternate splice donor choice. Given the theoretical function of
AKAPs, it appears reasonable that these splice variants may
define either specific intracellular targeting for particular
AKAP350 isoforms in different cell types or their association
with specific scaffolding components.
Alternative splicing of this nature has been well character-
ized in several complex spliced protein families including odor-
ant receptors (31), neurexins (32), and myofibrillar proteins
(33). Contractile protein genes provide a model system for
study of this process. Either a particular gene among members
of a multigene family is selected for expression or a spectrum of
different proteins may be generated from a single gene. A
prime example of both is found in troponin T, a member of the
thin filament of vertebrate sarcomere with specific subtypes in
cardiac as well as fast and slow skeletal muscle (Tc, Tf, Ts).
Each subtype is coded by a gene with a unique promoter region
and terminates at a single polyadenylation site. Within each
subtype, however, a series of adjacent exons are intermittently
spliced out, forming a large number of isoforms (32 for Tf) coded
by the same gene. Gene transcripts are assembled from varia-
tions in both donor and acceptor splice site selection (33).
The results of our investigations have shown that AKAP350
and yotiao are products of the same genomic region on chro-
mosome 7q21. Yotiao was identified as a protein in brain that
interacts with the NMDA receptor subunit NR1 (29). Interest-
ingly, the regions that mediate this interaction also are present
in the amino-terminal region of AKAP350. Examination of the
FIG. 9. Association of AKAP350 with
centrosomes in polarized MDCK
cells. MDCK cells were grown on perme-
able filters for 3 days and then fixed. a–c,
cells were triple stained with polyclonal
anti-RII (a), murine monoclonal anti-
AKAP350 (14G2) (b), and rat monoclonal
anti-ZO-1 (tight junctions) (c). Cells were
imaged as maximum intensity projections
of 40 0.29-mm optical sections. The arrow-
heads show regions of colocalization of
AKAP350 staining with staining for RII.
d–l, cells were triple labeled with murine
monoclonal anti-AKAP350 (d, g, j), poly-
clonal anti-g-tubulin (e, h, k) and rat
monoclonal anti-ZO-1 (f). AKAP350 la-
beled the poles of the centrosomes assy-
metrically (arrowheads). Cells were im-
aged as maximum intensity projections of
40 0.29-mm optical sections. X-Y (g–i) and
X-Z (j–l) projections of a single pair of
centrioles shows that AKAP350 immuno-
reactivity was concentrated as a projec-
tion from one of the centrioles (dual label
overlaps in i and l). The projection always
was oriented away from the apical mem-
brane. A similar distribution was ob-
served for RII immunostaining (m) in as-
sociation with g-tubulin staining
centrioles (n). The dual label image (o) of
the X-Z reconstruction of a pair of centri-
oles shows a similar pattern of a projec-
tion from one pole of the centriole. Bar, 5
mm (a–c), 3 mm (d–f), 1 mm (g–o).
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genomic sequence region upstream of the yotiao coding region
suggests that there is a GC-rich putative promoter region. The
genomic region upstream of the 59-end of the AKAP350 se-
quence contains a putative TATA box and other putative reg-
ulatory elements. Thus, the two proteins probably have sepa-
rate transcriptional regulators. The 14G2 antibody that we
have used in our immunolocalization studies recognizes a re-
gion of AKAP350 that is not contained in yotiao. Thus, our
localization studies are specific for AKAP350. In contrast, the
antibodies used in studies of yotiao are raised against regions
that are predicted to cross-react with AKAP350 (29). Indeed, it
is interesting to note that the size of the major species observed
in whole brain was considerably larger than the size of yotiao
protein exogenously expressed in fibroblasts (29). Some of the
assignment of yotiao staining and distribution may need to be
reevaluated with more specific antisera against the far amino
or carboxyl termini of yotiao. In addition, it will be of interest to
identify whether AKAP350 in brain also interacts with an
NMDA receptor.
An extensive amount of study has been dedicated to eluci-
dating the function of the centrosome and its components as
they relate to the general physiology of the cell. The centrosome
is the principal microtubule organizing center in most cells,
composed of a pair of centrioles and a surrounding matrix, also
referred to as the pericentriolar material. Each centriole has
bilateral appendages at one pole known as transitional fibers
(34). g-Tubulin is a major component of the centriole cores in a
variety of cells (35), and several studies suggest that this pro-
tein may be essential for microtubule nucleation from centro-
somes (36). As one might expect for an organelle central to
cytoskeletal organization, a number of regulatory molecules
also are associated with the centrosome. The importance of
protein phosphorylation in microtubule nucleation is under-
scored by the presence of the p34cdc2 kinase and type II protein
kinase A at the centrosome (7, 8, 37). Keryer et al. (9) subse-
quently studied the distribution of RII isoforms a and b in a
human lymphoblast cell line, finding the RII-b localized to the
Golgi-centrosomal area. The characteristics of the 350-kDa
AKAP that we have cloned appear similar to those of the
centrosomal AKAP350 identified by Keryer et al. (9) in an RII
blot overlay of isolated centrosome proteins from the KE37
human lymphoblast cell line. These investigators immunopre-
cipitated the protein using the serum 0013 polyclonal antibody,
previously reported as a specific marker for human centro-
somes (20, 22, 38). No further characterization of this protein in
the literature has been submitted, however, since the initial
report. Nevertheless, several lines of evidence suggest that this
protein may indeed be identical to the protein cloned here.
First, Western blots with our 14G2 monoclonal antibody show
a similar pattern of 250- and 350-kDa proteins as seen by
Keryer et al. (9) with the 0013 polyclonal serum and RII over-
lays. Second, immunocytochemistry with the 14G2 monoclonal
antibody also shows prominent localization of the protein with
the centrosomes of both polarized and nonpolarized cells.
Third, as noted for the AKAP350 protein previously described,
the distribution of 14G2 immunoreactive protein in MDCK
cells was not altered by treatment of cells with nocodozole.
AKAPs are well characterized as scaffolding proteins, se-
questering the RII subunit and consequently the catalytic sub-
unit of the protein kinase A in a location where phosphoryla-
tion of a particular substrate will be needed for some key
regulatory process (39, 40). Centrosomes, as the site of micro-
tubule nucleation and mitotic spindle formation as well as a
binding site for several centrosome-associated proteins, provide
a host of possible substrates for regulation by protein kinase A
phosphorylation. A role for AKAPs in microtubule nucleation
has previously been established in the case of MAP-2 (3). In
immunocytochemical analysis, g-tubulin has become the
marker of choice for the centrosomes; however, it is now clear
that many cell types also have noncentrosomal pools of g-tubu-
lin. This does not seem to be the case in the MDCK cell line,
where g-tubulin staining and AKAP350 were limited to the
discrete pair of centrioles forming the centrosome. Parietal
cells, at the other end of the spectrum, display multiple foci of
AKAP350 labeling throughout the cell. These other sites do not
correlate with g-tubulin staining in parietal cells. While most
tissues and cells demonstrate AKAP350 distribution in associ-
ation with centrosomes, several epithelial cells also showed
noncentrosomal staining patterns. In the human airway epi-
thelial cell line, for example, the majority of AKAP350 staining
appears at the centrosome; however, it is also apparent in a
lateral subapical pattern. Similar permutations of AKAP350
distribution in these and other epithelial cells (e.g. colonic
epithelial cells) allow us to speculate that the protein kinase A
is probably targeted to cytoskeletal elements other than cen-
trosomes in many cell types.
Confocal immunofluorescence microscopy demonstrated
AKAP350 staining associated with large globular complexes
scattered throughout the cytosol of parietal cells, lending sup-
port to the idea that this protein is part of a complex of regu-
latory molecules. The presence of multiple AKAP350-contain-
ing structures in parietal cells may reflect its involvement in
the massive cytoskeletal reorganization that takes place when
parietal cells are stimulated to secrete acid (27). Other less
differentiated cell types, especially those that have undergone
transformation into a phase of unregulated growth, may re-
quire AKAP350 simply for microtubule nucleation at the cen-
trosome; hence, the distribution is strictly limited to this or-
ganelle. Examination of the mitotic spindle apparatus in the
FIG. 10. Noncentrosomal AKAP350 in cultured cells. Primary
cultures of gastric parietal cells (a, b) and cultured human bronchial
epithelial cells (c, d) were dual stained with antibodies against
AKAP350 (a, c) and g-tubulin (b–d). Single 0.29-mm optical sections
were used to evaluate the distribution of the immunostaining. In pari-
etal cells, while AKAP350 staining could be seen in association with
centrosomes (arrowheads), the majority of the staining was not associ-
ated with g-tubulin staining. In airway epithelial cells, the majority of
AKAP350 staining was associated with centrosomes, but discrete foci of
AKAP350 staining were also present in the apical region of the cell,
especially near the lateral borders (arrows). Bar, 3 mm.
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stages of mitosis in HeLa and HCT116 colon adenocarcinoma
cells demonstrated the presence of AKAP350 not only at the
centrosome throughout mitosis but also at the cleavage furrow
in anaphase and telophase for both cell types. This finding
might suggest a possible role for AKAP350 in establishment or
activation of contraction to form the contractile ring in telo-
phase cells. Interestingly, no RII was observed in association
with AKAP350 in the cleavage furrow. This may suggest that
an alternate splice variant, different from centrosomal
AKAP350, is associated with a different cytoskeletal system. Of
note, the extensive coiled-coil structure in AKAP350 shows
homology not only to centrosome-associated proteins (e.g. peri-
centrin) but also to intermediate filament-associated proteins
and myosins. In addition to alternate cytoskeletal association,
it is also likely that AKAP350 is scaffolding other regulators
beyond type II protein kinase A. Along these lines, AKAP79 is
associated with both protein phosphatase and protein kinase C
(28). Further investigations will be required to elucidate com-
ponents of the AKAP350 scaffolding complex and the basis of
its cytoskeletal targeting.
In summary, we have cloned and characterized a new family
of 350-kDa AKAPs that are the products of a multiply spliced
gene region that also produces the previously described yotiao
protein. In most tissues, AKAP350 localizes to the centrosome.
However, in several epithelial cell types, multiple extracentro-
somal foci are present. These results suggest that AKAP350
may be a multifunctional scaffolding protein.
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